Baxter Healthcare
Deerfield, Illinois, 60015, United States
NCT Number: NCT02083198
This observational study evaluates the impact of high and low chloride containing IV fluids on administrative and clinical outcomes. The study uses a large electronic health dataset and examines patients receiving fluid replacement and resuscitation. The hypothesis is that high chloride solutions are associated with adverse outcomes as measured by administrative data and by clinical parameters.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Deerfield, Illinois, 60015, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Hospitalization, Expected Length of inpatient stay is approximately 7 days
Inpatient mortality. Expected Length of inpatient stay is approximately 7 days
Time frame: inpatient hospitalization, Expected Length of inpatient stay is approximately 7 days
Time frame: inpatient hospitalization, Expected Length of inpatient stay is approximately 7 days
Time frame: inpatient hospitalization, Expected Length of inpatient stay is approximately 7 days
Time frame: inpatient hospitalization, Expected Length of inpatient stay is approximately 7 days
Time frame: inpatient hospitalizationExpected Length of inpatient stay is approximately 7 days
Time frame: 30, 60 and 90 day
Baxter Healthcare Corporation
Industry
A Comparison of High and Low Chloride Containing IV Fluid Solutions in Patients Undergoing Major Surgery and/or ICU Admission
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00736723
Critical Illness, Critically Ill
Ulm, Germany
View Trial DetailsNCT02922998
Antibiotic Resistant Infection, Critical Illness
Ulm, Germany
View Trial DetailsNCT03754257
Infections, Inflammation
São Paulo, Brazil
View Trial DetailsNCT05703802
Adiposity, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Münster, North Rhine-Westphalia, Germany
View Trial Details